‘We were close, then ran out of money’, says scientists on Hantavirus vaccine
Early animal trials showed an antibody could clear lung infection, but researchers say about $7 million is needed to advance human testing.
8 Articles
8 Articles
Vir loga Mar to Barr and his team in Chile have been working on antibodies to hantavirus for months before running out of funds.
A promising Chilean research has been developing a vaccine for hantavirus, specifically for the Andes strain, which can be transmitted among humans by close contact. However, it has not been able to advance to clinical studies with humans due to lack of funding. In Chile, there are no competitive funds to cover these costly researches and, in order to carry them out, scientists would need about 7 million dollars. Without many options, they hope …
Chilean researchers were on the verge of finding a vaccine against the hantavirus, before they had to stop their research during the Covid-19 pandemic, for lack of funding.
A possible hantavirus vaccine was nearly ready, then researchers suddenly ran out of money
A deadly hantavirus outbreak linked to a cruise ship travelling from Argentina towards Europe has once again pushed the rare Andes strain into global focus. The virus, known for causing severe respiratory illness and carrying a high fatality rate, has now sparked renewed concern among health authorities and researchers working on possible treatments. According to a Bloomberg News report, scientists in Chile had already spent years quietly workin…
Times of India
Hantavirus scientists were close to vaccine but ran out of money
Scientists in Chile developed antibodies that successfully neutralised the deadly Andes hantavirus in lab and animal studies, raising hopes for a treatment against the rare virus that can spread between people. But the project stalled before human trials due to lack of funding and the Covid-19 pandemic.
Coverage Details
Bias Distribution
- 86% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
